Yixintang Pharmaceutical Group Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 14,585.39 million compared to CNY 12,656.28 million a year ago. Net income was CNY 921.47 million compared to CNY 789.96 million a year ago.

Basic earnings per share from continuing operations was CNY 1.5613 compared to CNY 1.3803 a year ago.